EMMES Corporation Services

EMMES to Coordinate NCI Anal Cancer Prevention Study

Tuesday, September 23, 2014

With the support of The EMMES Corporation, clinical investigators from the AIDS Malignancy Consortium (AMC) are preparing to enroll HIV-infected men and women throughout the United States and Puerto Rico in a major investigation of a prevention strategy for anal cancer. The study will enroll over 5,000 participants who are HIV-infected and who have pre-cancerous lesions. EMMES will provide operations, data management, site monitoring, and regulatory support under the eight-year, $89 million award. The study is scheduled to begin enrollment this month.

Download Press Release